# Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17

> **NCT03558971** · PHASE4 · COMPLETED · sponsor: **Helen Foundation** · enrollment: 2430 (actual)

## Conditions studied

- Rheumatic Diseases

## Interventions

- **DRUG:** Cortisol

## Key facts

- **NCT ID:** NCT03558971
- **Lead sponsor:** Helen Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 2430 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03558971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03558971, "Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03558971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*